Feasibility and Clinical Value of CT-Guided 125I Brachytherapy for Pain Palliation in Patients With Breast Cancer and Bone Metastases After External Beam Radiotherapy Failure

医学 近距离放射治疗 乳腺癌 外照射放疗 放射治疗 止痛药 外科 缓和医疗 放射科 癌症 麻醉 内科学 护理部
作者
Jian He,Qicong Mai,Fangfang Yang,Wenhang Zhuang,Qing Gou,Zejian Zhou,Rongde Xu,Xiaoming Chen,Zhiqiang Mo
出处
期刊:Frontiers in Oncology [Frontiers Media]
卷期号:11 被引量:5
标识
DOI:10.3389/fonc.2021.627158
摘要

Objectives: To evaluate the feasibility and clinical value of CT-guided iodine-125 ( 125 I) brachytherapy for pain palliation in patients with breast cancer and bone metastases after external beam radiotherapy failure. Methods: From January 2014 to July 2016, a total of 90 patients, who had received the standard therapies for bone metastases but still suffered moderate-to-severe pain, were retrospectively studied. About 42 patients were treated with both 125 I brachytherapy and bisphosphonates (Group A), and 48 patients were treated with bisphosphonates alone (Group B). Results: In Group A, 45 125 I brachytherapy procedures were performed in 42 patients with 69 bone metastases; the primary success rate of 125 I seed implantation was 92.9%, without severe complications. Regarding pain progression of the two groups, Group A exhibited significant relief in “worst pain,” “least pain,” “average pain,” and “present pain” 3-day after treatment and could achieve a 12-week-remission for “worst pain,” “least pain,” “average pain,” and “present pain.” The morphine-equivalent 24-h analgesic dose at 3 days, 4 weeks, 8 weeks, and 12 weeks was 91 ± 27, 53 ± 13, 31 ± 17, and 34 ± 12 mg for Group A, and 129 ± 21, 61 ± 16, 53 ± 15, and 105 ± 23 mg for Group B. Group A experienced a lower incidence of analgesic-related adverse events and better quality of life than Group B. Conclusion: The CT-guided 125 I brachytherapy is a feasible and an effective treatment for the palliation of pain caused by bone metastases from breast cancer after external beam radiotherapy failure.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
五味杂陈完成签到,获得积分10
刚刚
Fang Xianxin发布了新的文献求助10
1秒前
1秒前
2秒前
nanaki给Tt的求助进行了留言
2秒前
2秒前
3秒前
虚心的惮完成签到 ,获得积分10
4秒前
Frank完成签到 ,获得积分10
4秒前
烂漫人达完成签到 ,获得积分10
5秒前
Liang完成签到,获得积分10
6秒前
TC发布了新的文献求助10
7秒前
传奇3应助枕星采纳,获得10
7秒前
凡凡发布了新的文献求助10
8秒前
免疫与代谢研究完成签到,获得积分10
9秒前
jiajiajai发布了新的文献求助10
10秒前
西早07完成签到,获得积分10
10秒前
Meng完成签到,获得积分10
11秒前
Neo完成签到,获得积分10
12秒前
keyaner完成签到,获得积分10
14秒前
童林艳完成签到,获得积分10
14秒前
ECHO完成签到,获得积分10
16秒前
Lucas应助Fang Xianxin采纳,获得10
17秒前
xiaoyao完成签到,获得积分10
18秒前
asss完成签到,获得积分10
18秒前
Y123发布了新的文献求助30
19秒前
LOVER完成签到 ,获得积分10
20秒前
松松完成签到 ,获得积分10
20秒前
22秒前
nater4ver完成签到,获得积分10
23秒前
UU发布了新的文献求助10
25秒前
超帅鸭子完成签到,获得积分10
25秒前
LXZ完成签到,获得积分10
25秒前
依惜完成签到,获得积分10
25秒前
zhaokunfeng关注了科研通微信公众号
25秒前
赫青亦完成签到 ,获得积分10
25秒前
exy完成签到,获得积分10
26秒前
zhaohu47完成签到,获得积分10
27秒前
超帅鸭子发布了新的文献求助10
27秒前
每每反完成签到,获得积分10
29秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029